This fact is mainly due to degradation by gastrointestinal tract enzymes and poor permeability of the intestinal mucosa [1, 4]. On the other hand, if protein and peptide drugs administer parenteral, multiple injections are required in order to achieve desirable therapeutic effects because of their short half-lives in vivo.
The multiple or frequent injections cause poor compliance.